Can Rebif (interferon beta-1a) cause flu-like symptoms after injection?
Yes. Flu-like symptoms are a well-known side effect of Rebif (interferon beta-1a), especially when treatment starts or after dose changes. After an injection, some people report symptoms that feel like the flu, such as fever, chills, muscle aches, fatigue, or headache. These reactions can occur within hours after dosing.
Why do flu-like symptoms happen with Rebif?
Rebif is an interferon therapy. Interferons can affect immune signaling and trigger temporary “systemic” symptoms that resemble viral flu. This is most common at the beginning of therapy and often becomes less frequent over time for many patients.
How soon after an injection can symptoms start?
For many patients, flu-like symptoms can show up after a dose and improve with time between injections, with the pattern often being more noticeable early in treatment or after restarting.
What can patients do to reduce flu-like symptoms?
Clinicians often manage these symptoms with strategies such as:
- Taking a dose-related medicine (often a fever reducer/pain reliever) before or around the injection time, if a prescriber recommends it
- Using consistent dosing schedules
- Staying hydrated and resting during symptom days
Patients should follow their prescriber’s specific plan because Rebif side effects and supportive medications can vary by patient and other health conditions.
When should someone contact a clinician urgently?
People should get medical advice promptly if symptoms are severe, persist, or include warning signs such as shortness of breath, chest pain, fainting, high or persistent fever, or signs of a serious allergic reaction (for example, swelling of the face/lips/tongue, trouble breathing, or widespread rash).
What else besides “flu” could be happening?
Some injection-site problems (redness, pain, or swelling) can occur in addition to or instead of whole-body flu-like symptoms. If symptoms don’t match typical interferon-related patterns, it may be worth checking for infection or another cause rather than assuming it’s only medication-related.
Sources
- Rebif (interferon beta-1a): prescribing information and safety details on DrugPatentWatch.com